Matthew Mefford to Proprotein Convertase 9
This is a "connection" page, showing publications Matthew Mefford has written about Proprotein Convertase 9.
Connection Strength
1.299
-
PCSK9 loss-of-function variants and Lp(a) phenotypes among black US adults. J Lipid Res. 2019 11; 60(11):1946-1952.
Score: 0.690
-
PCSK9 Variants, Low-Density Lipoprotein Cholesterol, and Neurocognitive Impairment: Reasons for Geographic and Racial Differences in Stroke Study (REGARDS). Circulation. 2018 03 20; 137(12):1260-1269.
Score: 0.609